BDBM415992 ((2R,5S)-5- isopropoxytetrahydro- 2H-pyran-2-yl)(8-(1- methyl-1H-pyrazol-4- yl)-5,11-dihydro-6H- benzo[b]pyrido[2,3- e][1,4]diazepin-6- yl)methanone::US10442819, Example 140

SMILES CC(C)O[C@H]1CC[C@@H](OC1)C(=O)N1Cc2cccnc2Nc2ccc(cc12)-c1cnn(C)c1

InChI Key InChIKey=CRIJWPATAQSMQE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 415992   

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM415992(US10442819, Example 140 | ((2R,5S)-5- isopropoxyte...)
Affinity DataIC50: 14nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent